Active substance
Butenafine
- SFDA 6
- US FDA 5
- US price lines 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| BUTAFYL 1% W/V SPRAY | 1 % | Spray · Topical | 1 Spray Container | SAR 38.90 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| BUTAFYL 1% cream | 1 % | Cream · Topical | 1 Tube | SAR 20.85 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| Butafyl | 1 % (W/W) | Cream · Topical | 1 Tube | SAR 41.70 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| DERFINA 1% CREAM | 1 % | Cream · Topical | 1 Tube | SAR 23.15 | NCE · Prescription | Jazeera Pharmaceutical Industries (JPI) | Withdrawn by MAH · Not Marketed |
| DERFINA 1% LOTION | 1 % | Lotion · Topical | 1 Spray Pump | SAR 42.70 | NCE · Prescription | Jazeera Pharmaceutical Industries (JPI) | Withdrawn by MAH · Not Marketed |
| DERFINA 1% SPRAY | 1 % | Spray · Topical | 1 Spray Pump | SAR 43.20 | NCE · Prescription | Jazeera Pharmaceutical Industries (JPI) | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
TINEA CORPORIS, TINEA CRURIS, AND TINEA PEDIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MENTAX | 1% | cream · topical | MYLAN BERTEK | Prescription | 31 Dec 1996 |
| LOTRIMIN ULTRA | 1% | cream · topical | BAYER HEALTHCARE LLC | Over-the-counter | 7 Dec 2001 |
| BUTENAFINE HYDROCHLORIDE | 1% | cream · topical | SUN PHARMA CANADA | Over-the-counter | 16 Nov 2017 |
| MENTAX | 1% | cream · topical | PHARMOBEDIENT | Discontinued | 18 Oct 1996 |
| MENTAX-TC | 1% | cream · topical | PHARMOBEDIENT | Discontinued | 17 Oct 2002 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | BUTENAFINE HCL 1% CREAM | $0.30701 | per GM | 23 Sep 2026 |
| US NADAC | BUTENAFINE HCL 1% CREAM | $0.53005 | per GM | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.